Related Experiment Video
Updated: Jan 31, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Therapeutic Options in Diffuse Large B-Cell Lymphoma - A Retrospective Study and Review of the Literature
Ana-Maria Patrascu1, Janina Nacea1, Ş Patrascu2
1Department of Hematology, University of Medicine and Pharmacy of Craiova, Romania.
Abstract:
The aim of this retrospective study was to assess the differences between standard R-CHOP and other Rituximab-associated chemotherapy (R-miniCHOP and R-CHOEP) regimens in terms of survival and potential adverse effects. The six-month survival outcomes of 94 diffuse large B-cell lymphomas (DLBCL) patients indicated no statistical difference between overall survival and disease-free survival in the two subgroups. The biological response to therapy (blood count, LDH levels) was similar in both subgroups. Despite having different clinical indications, R-miniCHOP and R-CHOEP provide viable therapeutic alternatives to the standard R-CHOP regimen.
Related Concept Videos
Diffusion
Diffusion
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Therapeutic Index

